当前位置: X-MOL 学术Signal Transduct. Target Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2024-05-27 , DOI: 10.1038/s41392-024-01828-x
Qingmiao Shi 1 , Chen Xue 1 , Yifan Zeng 1 , Xin Yuan 1 , Qingfei Chu 1 , Shuwen Jiang 1 , Jinzhi Wang 1 , Yaqi Zhang 1 , Danhua Zhu 1 , Lanjuan Li 1
Affiliation  

Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue homeostasis across metazoans, is highly conserved throughout evolution. The Notch receptor and its ligands are transmembrane proteins containing epidermal growth factor-like repeat sequences, typically necessitating receptor-ligand interaction to initiate classical Notch signaling transduction. Accumulating evidence indicates that the Notch signaling pathway serves as both an oncogenic factor and a tumor suppressor in various cancer types. Dysregulation of this pathway promotes epithelial-mesenchymal transition and angiogenesis in malignancies, closely linked to cancer proliferation, invasion, and metastasis. Furthermore, the Notch signaling pathway contributes to maintaining stem-like properties in cancer cells, thereby enhancing cancer invasiveness. The regulatory role of the Notch signaling pathway in cancer metabolic reprogramming and the tumor microenvironment suggests its pivotal involvement in balancing oncogenic and tumor suppressive effects. Moreover, the Notch signaling pathway is implicated in conferring chemoresistance to tumor cells. Therefore, a comprehensive understanding of these biological processes is crucial for developing innovative therapeutic strategies targeting Notch signaling. This review focuses on the research progress of the Notch signaling pathway in cancers, providing in-depth insights into the potential mechanisms of Notch signaling regulation in the occurrence and progression of cancer. Additionally, the review summarizes pharmaceutical clinical trials targeting Notch signaling for cancer therapy, aiming to offer new insights into therapeutic strategies for human malignancies.



中文翻译:


癌症中的Notch信号通路:从机制见解到靶向治疗



Notch信号以其在后生动物中调节细胞命运、器官发育和组织稳态中的作用而闻名,在整个进化过程中高度保守。 Notch 受体及其配体是含有表皮生长因子样重复序列的跨膜蛋白,通常需要受体-配体相互作用才能启动经典的 Notch 信号转导。越来越多的证据表明,Notch 信号通路在各种癌症类型中既是致癌因子,又是肿瘤抑制因子。该通路的失调会促进恶性肿瘤中的上皮间质转化和血管生成,与癌症增殖、侵袭和转移密切相关。此外,Notch信号通路有助于维持癌细胞的干细胞样特性,从而增强癌症的侵袭性。 Notch信号通路在癌症代谢重编程和肿瘤微环境中的调节作用表明其在平衡致癌和肿瘤抑制作用中发挥着关键作用。此外,Notch 信号通路与赋予肿瘤细胞化疗耐药性有关。因此,全面了解这些生物过程对于开发针对 Notch 信号传导的创新治疗策略至关重要。本文重点综述Notch信号通路在癌症中的研究进展,深入探讨Notch信号调控在癌症发生和进展中的潜在机制。此外,该综述还总结了针对癌症治疗的 Notch 信号传导的药物临床试验,旨在为人类恶性肿瘤的治疗策略提供新的见解。

更新日期:2024-05-27
down
wechat
bug